Key points are not available for this paper at this time.
Phage therapy is a promising therapeutic strategy in the treatment of bacterial infections, especially those resistant to antibiotics. It consists of the use of bacteriophages, viruses that selectively infect and destroy bacteria. Bacteriophages can replicate within pathogenic bacteria, offering a precise alternative to conventional antibiotics. It has shown encouraging results in preclinical and clinical studies, showing efficacy in infections unresponsive to antibiotics. Bacteriophages can be customized to target specific bacterial strains, allowing for an individualized approach to treatment. Although there are challenges and limitations, significant advances are being made in this field. More research and regulation is required for its development and wider adoption. Phage therapy offers real hope in the treatment of bacterial infections, but its potential impact on public health needs further investigation.
Molina et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: